CIK 0001770121 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Sana Biotechnology, Inc.
Sign in to watch- Ticker
- SANA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831381173
- Phone
- (206) 701-7914
- Business address
- 188 EAST BLAINE STREET, SUITE 350, SEATTLE, WA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-05 | Bishop Hans Edgar Director | Grant or award | +8,680 | 5,863,480 | ||
| 2026-08-27 | PATEL DHAVALKUMAR DHIRAJLAL EVP, Chief Scientific Officer | Shares withheld for taxes | −41,158 | $4.11 | $169K | 183,352 |
| 2026-08-26 | PATEL DHAVALKUMAR DHIRAJLAL EVP, Chief Scientific Officer | Option exercise | +125,000 | 224,510 | ||
| 2026-08-26 | PATEL DHAVALKUMAR DHIRAJLAL EVP, Chief Scientific Officer | Option exercise · Restricted Stock Units | −125,000 | 250,000 | ||
| 2026-07-06 | Bishop Hans Edgar Director | Grant or award | +6,297 | 5,854,800 | ||
| 2026-06-04 | Seitz Michelle Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-06-04 | NELSEN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-06-04 | REICIN ALISE Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-06-04 | Rosiello Robert L. Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-06-04 | Bilenker Joshua H. Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-06-04 | Bishop Hans Edgar Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-06-04 | Mulligan Richard Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-06-04 | Yang Patrick Y Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2026-04-06 | Bishop Hans Edgar Director | Grant or award | +7,763 | 5,848,503 | ||
| 2026-03-09 | Harr Steve President & CEO | Shares withheld for taxes | −11,526 | $3.13 | $36K | 7,957,070 |
| 2026-03-09 | Harr Steve President & CEO | Shares withheld for taxes | −12,819 | $3.10 | $40K | 7,944,251 |
| 2026-03-09 | Wyrick Susan D. See Remarks | Shares withheld for taxes | −3,342 | $3.13 | $10K | 197,241 |
| 2026-03-09 | Wyrick Susan D. See Remarks | Shares withheld for taxes | −1,045 | $3.10 | $3K | 196,196 |
| 2026-03-07 | Harr Steve President & CEO | Option exercise | +50,000 | 7,968,596 | ||
| 2026-03-07 | Harr Steve President & CEO | Option exercise · Restricted Stock Units | −50,000 | 100,000 |
Page 1 of 9 · 172 trades